{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:14:51Z","timestamp":1788786891272,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["LY18H070002"],"award-info":[{"award-number":["LY18H070002"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ13H020006"],"award-info":[{"award-number":["LQ13H020006"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20140660"],"award-info":[{"award-number":["Y20140660"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20160097"],"award-info":[{"award-number":["Y20160097"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20180063"],"award-info":[{"award-number":["Y20180063"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400273"],"award-info":[{"award-number":["81400273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010903","name":"National Science Foundation of China | Key Programme","doi-asserted-by":"publisher","award":["2017YFA0506000"],"award-info":[{"award-number":["2017YFA0506000"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010903","name":"National Science Foundation of China | Key Programme","doi-asserted-by":"publisher","award":["2017YFA0506000"],"award-info":[{"award-number":["2017YFA0506000"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010903","name":"National Science Foundation of China | Key Programme","doi-asserted-by":"publisher","award":["2017YFA0506000"],"award-info":[{"award-number":["2017YFA0506000"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010905","name":"National Science Foundation of China | Major Research Plan","doi-asserted-by":"publisher","award":["81473261"],"award-info":[{"award-number":["81473261"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010905","name":"National Science Foundation of China | Major Research Plan","doi-asserted-by":"publisher","award":["81874323"],"award-info":[{"award-number":["81874323"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endothelial dysfunction initiates and exacerbates hypertension, atherosclerosis and other cardiovascular complications in diabetic mellitus. FGF21 is a hormone that mediates a number of beneficial effects relevant to metabolic disorders and their associated complications. Nevertheless, it remains unclear as to whether FGF21 ameliorates endothelial dysfunction. Therefore, we investigated the effect of FGF21 on endothelial function in both type 1 and type 2 diabetes. We found that FGF21 reduced hyperglycemia and ameliorated insulin resistance in type 2 diabetic mice, an effect that was totally lost in type 1 diabetic mice. However, FGF21 activated AMPK\u03b1, suppressing oxidative stress and enhancing endothelium-dependent vasorelaxation of aorta in both types, suggesting a mechanism that is independent of its glucose-lowering and insulin-sensitizing effects. In vitro, we identified a direct action of FGF21 on endothelial cells of the aorta, in which it bounds to FGF receptors to alleviate impaired endothelial function challenged with high glucose. Furthermore, the CaMKK2-AMPK\u03b1 signaling pathway was activated to suppress oxidative stress. Apart from its anti-oxidative capacity, FGF21 activated eNOS to dilate the aorta via CaMKK2\/AMPK\u03b1 activation. Our data suggest expanded potential uses of FGF21 for the treatment of vascular diseases in diabetes.<\/jats:p>","DOI":"10.1038\/s41419-019-1893-6","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T10:02:43Z","timestamp":1568196163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2\/AMPK\u03b1 signaling pathway"],"prefix":"10.1038","volume":"10","author":[{"given":"Lei","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonglin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"1893_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","volume":"100","author":"SM Grundy","year":"1999","unstructured":"Grundy, S. M. et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100, 1134\u20131146 (1999).","journal-title":"Circulation"},{"key":"1893_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","volume":"11","author":"CE Tabit","year":"2010","unstructured":"Tabit, C. E., Chung, W. B., Hamburg, N. M. & Vita, J. A. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev. Endocr. Metab. Disord. 11, 61\u201374, https:\/\/doi.org\/10.1007\/s11154-010-9134-4 (2010).","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"1893_CR3","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1042\/BST20140113","volume":"42","author":"Andrew Shaw","year":"2014","unstructured":"Shaw, A., Doherty, M. K., Mutch, N. J., MacRury, S. M. & Megson, I. L. Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications? Biochem Soc Trans. 42, 928\u2013933, https:\/\/doi.org\/10.1042\/BST20140113 (2014).","journal-title":"Biochemical Society Transactions"},{"key":"1893_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2337\/db06-1580","volume":"56","author":"KK Cheng","year":"2007","unstructured":"Cheng, K. K. et al. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56, 1387\u20131394, https:\/\/doi.org\/10.2337\/db06-1580 (2007).","journal-title":"Diabetes"},{"key":"1893_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7156941","volume":"2017","author":"Ying Liang","year":"2017","unstructured":"Liang, Y. et al. Research Progress on Signaling Pathway-Associated Oxidative Stress in Endothelial Cells. Oxid. Med. Cell Longev. 2017, 7156941, https:\/\/doi.org\/10.1155\/2017\/7156941 (2017).","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1893_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/CIRCRESAHA.116.306531","volume":"119","author":"PM Vanhoutte","year":"2016","unstructured":"Vanhoutte, P. M., Zhao, Y., Xu, A. & Leung, S. W. Thirty years of saying NO: sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator. Circ. Res. 119, 375\u2013396, https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.306531 (2016).","journal-title":"Circ. Res."},{"key":"1893_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","volume":"1492","author":"T Nishimura","year":"2000","unstructured":"Nishimura, T., Nakatake, Y., Konishi, M. & Itoh, N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys. Acta 1492, 203\u2013206 (2000).","journal-title":"Biochim Biophys. Acta"},{"key":"1893_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher, F. M. & Maratos-Flier, E. Understanding the Physiology of FGF21. Annu Rev. Physiol. 78, 223\u2013241, https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105339 (2016).","journal-title":"Annu Rev. Physiol."},{"key":"1893_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.molmet.2013.12.003","volume":"3","author":"A Kharitonenkov","year":"2014","unstructured":"Kharitonenkov, A. & Adams, A. C. Inventing new medicines: the FGF21 story. Mol. Metab. 3, 221\u2013229, https:\/\/doi.org\/10.1016\/j.molmet.2013.12.003 (2014).","journal-title":"Mol. Metab."},{"key":"1893_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","volume":"5","author":"MK Badman","year":"2007","unstructured":"Badman, M. K. et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426\u2013437, (2007).","journal-title":"Cell Metab."},{"key":"1893_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki, T. et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415\u2013425, (2007).","journal-title":"Cell Metab."},{"key":"1893_CR12","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest 115, 1627\u20131635, https:\/\/doi.org\/10.1172\/JCI23606 (2005).","journal-title":"J. Clin. Invest"},{"key":"1893_CR13","doi-asserted-by":"publisher","first-page":"12983","DOI":"10.1074\/jbc.M110.215889","volume":"286","author":"E Hondares","year":"2011","unstructured":"Hondares, E. et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J. Biol. Chem. 286, 12983\u201312990, https:\/\/doi.org\/10.1074\/jbc.M110.215889 (2011).","journal-title":"J. Biol. Chem."},{"key":"1893_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fendo.2014.00018","volume":"5","author":"H Ohta","year":"2014","unstructured":"Ohta, H. & Itoh, N. Roles of FGFs as adipokines in adipose tissue development, remodeling, and metabolism. Front. Endocrinol. (Lausanne) 5, 18, (2014).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"1893_CR15","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","volume":"59","author":"FM Fisher","year":"2010","unstructured":"Fisher, F. M. et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 59, 2781\u20132789, https:\/\/doi.org\/10.2337\/db10-0193 (2010).","journal-title":"Diabetes"},{"key":"1893_CR16","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.2337\/db13-0645","volume":"62","author":"WY So","year":"2013","unstructured":"So, W. Y. et al. High glucose represses beta-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor gamma signaling. Diabetes 62, 3751\u20133759, https:\/\/doi.org\/10.2337\/db13-0645 (2013).","journal-title":"Diabetes"},{"key":"1893_CR17","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","volume":"131","author":"Z Lin","year":"2015","unstructured":"Lin, Z. et al. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice. Circulation 131, 1861\u20131871, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015308 (2015).","journal-title":"Circulation"},{"key":"1893_CR18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cmet.2018.04.002","volume":"27","author":"X Pan","year":"2018","unstructured":"Pan, X. et al. FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2\/angiotensin-(1-7) axis in mice. Cell Metab. 27, 1323\u20131337 e1325, (2018).","journal-title":"Cell Metab."},{"key":"1893_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cvr\/cvu263","volume":"106","author":"A Planavila","year":"2015","unstructured":"Planavila, A. et al. Fibroblast growth factor 21 protects the heart from oxidative stress. Cardiovasc Res. 106, 19\u201331, https:\/\/doi.org\/10.1093\/cvr\/cvu263 (2015).","journal-title":"Cardiovasc Res"},{"key":"1893_CR20","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1210\/en.2012-2276","volume":"154","author":"HW Kim","year":"2013","unstructured":"Kim, H. W. et al. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db\/db mice. Endocrinology 154, 3366\u20133376, https:\/\/doi.org\/10.1210\/en.2012-2276 (2013).","journal-title":"Endocrinology"},{"key":"1893_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrd.2015.9","volume":"15","author":"C Degirolamo","year":"2016","unstructured":"Degirolamo, C., Sabba, C. & Moschetta, A. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nat. Rev. Drug Discov. 15, 51\u201369, https:\/\/doi.org\/10.1038\/nrd.2015.9 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1893_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00418-004-0678-9","volume":"122","author":"GL King","year":"2004","unstructured":"King, G. L. & Loeken, M. R. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol. 122, 333\u2013338, https:\/\/doi.org\/10.1007\/s00418-004-0678-9 (2004).","journal-title":"Histochem Cell Biol."},{"key":"1893_CR23","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1161\/CIRCULATIONAHA.112.108159","volume":"126","author":"FY Li","year":"2012","unstructured":"Li, F. Y. et al. Endothelium-selective activation of AMP-activated protein kinase prevents diabetes mellitus-induced impairment in vascular function and reendothelialization via induction of heme oxygenase-1 in mice. Circulation 126, 1267\u20131277, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.108159 (2012).","journal-title":"Circulation"},{"key":"1893_CR24","doi-asserted-by":"publisher","first-page":"E7276","DOI":"10.1073\/pnas.1512867112","volume":"112","author":"SA Head","year":"2015","unstructured":"Head, S. A. et al. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK\/mTOR signaling axis in endothelial cells. Proc. Natl Acad. Sci. USA 112, E7276\u2013E7285, https:\/\/doi.org\/10.1073\/pnas.1512867112 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1893_CR25","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1210\/me.2010-0142","volume":"24","author":"K Fon Tacer","year":"2010","unstructured":"Fon Tacer, K. et al. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24, 2050\u20132064, (2010).","journal-title":"Mol. Endocrinol."},{"key":"1893_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/08977190500096004","volume":"23","author":"M Antoine","year":"2005","unstructured":"Antoine, M. et al. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors 23, 87\u201395, https:\/\/doi.org\/10.1080\/08977190500096004 (2005).","journal-title":"Growth Factors"},{"key":"1893_CR27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ki.2013.332","volume":"85","author":"R Jimbo","year":"2014","unstructured":"Jimbo, R. et al. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int. 85, 1103\u20131111, https:\/\/doi.org\/10.1038\/ki.2013.332 (2014).","journal-title":"Kidney Int."},{"key":"1893_CR28","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1158\/1535-7163.MCT-16-0136","volume":"15","author":"WS Brown","year":"2016","unstructured":"Brown, W. S., Tan, L., Smith, A., Gray, N. S. & Wendt, M. K. Covalent targeting of fibroblast growth factor receptor inhibits metastatic breast cancer. Mol. Cancer Ther. 15, 2096\u20132106, https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0136 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"1893_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2011.05.009","volume":"14","author":"WT Wong","year":"2011","unstructured":"Wong, W. T. et al. Adiponectin is required for PPARgamma-mediated improvement of endothelial function in diabetic mice. Cell Metab. 14, 104\u2013115, (2011).","journal-title":"Cell Metab."},{"key":"1893_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251\u2013262, https:\/\/doi.org\/10.1038\/nrm3311 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1893_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2016.12.004","volume":"25","author":"KC Coate","year":"2017","unstructured":"Coate, K. C. et al. FGF21 Is an Exocrine Pancreas Secretagogue. Cell Metab. 25, 472\u2013480, https:\/\/doi.org\/10.1016\/j.cmet.2016.12.004 (2017).","journal-title":"Cell Metab."},{"key":"1893_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.20847","volume":"210","author":"JS Moyers","year":"2007","unstructured":"Moyers, J. S. et al. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J. Cell Physiol. 210, 1\u20136, https:\/\/doi.org\/10.1002\/jcp.20847 (2007).","journal-title":"J. Cell Physiol."},{"key":"1893_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/cr.2017.45","volume":"27","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Fasting-induced hormonal regulation of lysosomal function. Cell Res. 27, 748\u2013763, (2017).","journal-title":"Cell Res."},{"key":"1893_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cmet.2008.02.011","volume":"7","author":"KA Anderson","year":"2008","unstructured":"Anderson, K. A. et al. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 7, 377\u2013388, (2008).","journal-title":"Cell Metab."},{"key":"1893_CR35","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.peptides.2011.05.014","volume":"32","author":"ZB Andrews","year":"2011","unstructured":"Andrews, Z. B. Central mechanisms involved in the orexigenic actions of ghrelin. Peptides 32, 2248\u20132255, (2011).","journal-title":"Peptides"},{"key":"1893_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","volume":"2","author":"SA Hawley","year":"2005","unstructured":"Hawley, S. A. et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9\u201319, (2005).","journal-title":"Cell Metab."},{"key":"1893_CR37","doi-asserted-by":"publisher","first-page":"15813","DOI":"10.1074\/jbc.M201075200","volume":"277","author":"H Tokumitsu","year":"2002","unstructured":"Tokumitsu, H. et al. STO-609, a specific inhibitor of the Ca(2+)\/calmodulin-dependent protein kinase kinase. J. Biol. Chem. 277, 15813\u201315818, https:\/\/doi.org\/10.1074\/jbc.M201075200 (2002).","journal-title":"J. Biol. Chem."},{"key":"1893_CR38","first-page":"H1303","volume":"267","author":"FW Sellke","year":"1994","unstructured":"Sellke, F. W. et al. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am. J. Physiol. 267, H1303\u2013H1311, (1994).","journal-title":"Am. J. Physiol."},{"key":"1893_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ijo.2009.205","volume":"34","author":"G Deng","year":"2010","unstructured":"Deng, G., Long, Y., Yu, Y. R. & Li, M. R. Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway. Int J. Obes. (Lond.) 34, 165\u2013171, https:\/\/doi.org\/10.1038\/ijo.2009.205 (2010).","journal-title":"Int J. Obes. (Lond.)"},{"key":"1893_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(06)68341-4","volume":"367","author":"D Daneman","year":"2006","unstructured":"Daneman, D. Type 1 diabetes. Lancet 367, 847\u2013858, https:\/\/doi.org\/10.1016\/S0140-6736(06)68341-4 (2006).","journal-title":"Lancet"},{"key":"1893_CR41","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840\u2013846, https:\/\/doi.org\/10.1038\/nature05482 (2006).","journal-title":"Nature"},{"key":"1893_CR42","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","volume":"24","author":"A Ceriello","year":"2004","unstructured":"Ceriello, A. & Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb. Vasc. Biol. 24, 816\u2013823, https:\/\/doi.org\/10.1161\/01.ATV.0000122852.22604.78 (2004).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"1893_CR43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa, T. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787\u2013790, https:\/\/doi.org\/10.1038\/35008121 (2000).","journal-title":"Nature"},{"key":"1893_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/DMSO.S43731","volume":"7","author":"KA Coughlan","year":"2014","unstructured":"Coughlan, K. A., Valentine, R. J., Ruderman, N. B. & Saha, A. K. AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab. Syndr. Obes. 7, 241\u2013253, https:\/\/doi.org\/10.2147\/DMSO.S43731 (2014).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"1893_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0891-5849(94)90079-5","volume":"17","author":"C Michiels","year":"1994","unstructured":"Michiels, C., Raes, M., Toussaint, O. & Remacle, J. Importance of Se-glutathione peroxidase, catalase, and Cu\/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17, 235\u2013248 (1994).","journal-title":"Free Radic. Biol. Med."},{"key":"1893_CR46","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12192-012-0331-9","volume":"17","author":"M Mohammadzadeh","year":"2012","unstructured":"Mohammadzadeh, M. et al. Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity. Cell Stress Chaperones 17, 553\u2013565, https:\/\/doi.org\/10.1007\/s12192-012-0331-9 (2012).","journal-title":"Cell Stress Chaperones"},{"key":"1893_CR47","first-page":"811","volume":"6","author":"G Scapagnini","year":"2004","unstructured":"Scapagnini, G. et al. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal 6, 811\u2013818, (2004).","journal-title":"Antioxid Redox Signal"},{"key":"1893_CR48","doi-asserted-by":"publisher","first-page":"H64","DOI":"10.1152\/ajpheart.00597.2010","volume":"300","author":"RJ Ford","year":"2011","unstructured":"Ford, R. J. & Rush, J. W. Endothelium-dependent vasorelaxation to the AMPK activator AICAR is enhanced in aorta from hypertensive rats and is NO and EDCF dependent. Am. J. Physiol. Heart Circ. Physiol. 300, H64\u2013H75, https:\/\/doi.org\/10.1152\/ajpheart.00597.2010 (2011).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1893_CR49","doi-asserted-by":"publisher","first-page":"15694","DOI":"10.1074\/jbc.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang, X. et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694\u201315700, https:\/\/doi.org\/10.1074\/jbc.M601252200 (2006).","journal-title":"J. Biol. Chem."},{"key":"1893_CR50","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1016\/j.biomaterials.2014.03.023","volume":"35","author":"LT Song","year":"2014","unstructured":"Song, L. T. et al. A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog. Biomaterials 35, 5206\u20135215, (2014).","journal-title":"Biomaterials"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1893-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1893-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1893-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:32:34Z","timestamp":1671211954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1893-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["1893"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1893-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"665"}}